No data to
display.
Puma Biotechnology, Inc. revenue increases to $56.12 million in quarter ended Sep 30, 2023 from previous quarter
By NewsInMinutes on Nov 04, 2023 | 05:34 AM IST
| Current Reporting | Revenue | Net Income | Profit/Loss |
|---|---|---|---|
| Sep 2023 | $56.12 million | $5.80 million | profit |
| Jun 2023 | $54.57 million | $2.13 million | profit |
| Mar 2023 | $52.78 million | $1.40 million | profit |
Puma Biotechnology, Inc. [PBYI] has reported $5.80 million profit for the fiscal quarter ending Sep 30, 2023.
Revenue for the quarter was $56.12 million with operating income of $8.58 million.
The Losangeles, California (CA)-based company operating in the pharmaceutical preparations sector has total shareholders equity of $38.74 million.
Also read:
This is a developing story. Click here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.